Retinal Vein Occlusion Recruiting Phase 2 / 3 Trials for Fasudil (DB08162)

Also known as: Occlusion Retinal Vein / Retinal-vein occlusion / Retinal Vein Occlusions(RVO) / Retinal Vein Occlusion (RVO) / Retinal Vein Occlusions

IndicationStatusPhase
DBCOND0000674 (Retinal Vein Occlusion)Recruiting2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03391219Combined Intravitreal Injection of Bevacizumab and Fasudil Versus Bevacizumab Alone for Macular Edema Secondary to Retinal Vein Occlusion in Previously Treated PatientsTreatment